You are here: Industry Insights > Vaccine

News List

NewLink Genetics selects Cevec’s CAP Technologies to develop Zika vaccine pharmaceutical-technology
February 13, 2017
German company Cevec Pharmaceuticals has signed an agreement with NewLink Genetics for the use of its CAPGT and CAPGo cell lines in the development and commercialisation of products to treat Zika virus infections.
Sanofi creates vaccine growth in 2016 despite lifeless Dengvaxia launch fiercepharma
February 09, 2017
In spite of trouble picking up steam with its first-of-a-kind dengue shot, Sanofi’s vaccines unit chipped in with 8.8% growth on the year, providing a boost for the company as other units failed to hold their ground.
Zika vaccine for women of childbearing age unlikely before 2020, WHO says fiercepharma
February 08, 2017
Despite the enormous effort, though, a vaccine for women of childbearing age may not be available before 2020, the World Health Organization estimates.
Trump's 'vaccine hesitant’ views run against public opinion, Pew says fiercepharma
February 07, 2017
As many experts wait anxiously to see how President Donald Trump might act on vaccines, a new survey documents strong support by Americans that the benefits of childhood immunizations outweigh any potential risks.
Novavax hopes to revive RSV vaccine with a new phase 2 trial fiercepharma
January 25, 2017
Novavax has started a new phase 2 trial on its key respiratory syncytial virus vaccine candidate in an effort to breathe new life into a program that was hit hard last fall with disheartening late stage data.
Expert 'apprehensive' about Trump's vaccine intentions, but waiting for more details fiercepharma
January 25, 2017
Having witnessed antivaccine sentiments swell in Texas, Sabin Vaccine Institute President Peter Hotez worries the feelings will intensify around the country.
Best Ways to Steer Clear of the Flu drugs.com
January 22, 2017
The best way for people to protect themselves from the flu is to get vaccinated -- and it's not too late to get a shot, an infectious diseases expert says.
Deals this week: Shenzhen Kangtai Biological Products, Telix Pharmaceuticals, Fresenius Finance Irel pharmaceutical-technology
January 22, 2017
Chinese vaccine and biologic products developer and manufacturer Shenzhen Kangtai Biological Products has announced the pricing for an initial public offering (IPO) of shares to raise ¥138.2m ($20.08m) in gross proceeds.
Measles-rubella vaccine to roll out in February financialexpress
January 13, 2017
Commonly known as German Measles, congenital rubella infection is believed to affect approximately 25,000 children born in India every year
Bavarian Nordic sees 'huge potential' in cancer vaccine combos, CEO says fiercepharma
January 11, 2017
As interest in cancer vaccine combos surges, Bavarian Nordic is inclined to remain an independent vaccine company, according to CEO Paul Chaplin.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page